Click it and Unblock the Notifications
Just In
Don't Miss
-
Palang Tod OTT Release Date: When & Where To Watch Ullu App Web Series Siskiyaan Season 3? Is New Season On Ca -
DC vs GT IPL 2024: Why Shubman Gill Held Back Spinner R Sai Kishore Till 19th over? -
Escape to Kalimpong, Gangtok, and Darjeeling with IRCTC's Tour Package; Check Itinerary -
DCB Bank Q4 Results: PAT Grew 9% To Rs 156 Cr, NII Jumps 4.5%; Dividend Declared -
OPPO Find X7 Ultra Camera Deep-Dive: Pushing the Boundaries of Photography on a Smartphone -
MP Board Class 10th, 12th Results 2024, Know Alternative Ways to Check Your Result -
Aston Martin Vantage Launched In India At Rs 3.99 Crore -
Summer Style: 6 Must-Try Colors To Stay Fashionably Cool Like B-Town Divas!
Significant data on nasal vaccine soon says Bharat Biotech
New Delhi, July 30: Bharat Biotech said that the company was expecting significant data on its intranasal COVID-19 vaccine in the next two and half months.
In another two and half months, we are going to have significant data, the company's founder Krishna Ella said.
The nasal vaccine is perceived to be a game changer in the battle against COVID-19. It is also believed to be more effective, since it is expected to generate immune responses at the site of the infection. It is also easy to scale it up and can produce 100 million doses a month, Ella told a FICCI Capital Markets Conference.
According to World Health Organisation this nasal vaccines whose clinical trials are underway in India could be a game changer for children.
They could also make for useful booster shots against emerging variants of the virus. And if they work for COVID-19, some immunologists hope that they could kick off a new wave of investment in intranasal vaccines for other diseases.
